Page last updated: 2024-10-29

imipramine and Leukemia, Myeloid

imipramine has been researched along with Leukemia, Myeloid in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortellazzo, S1
Viero, P1
Buczko, W1
Barbui, T1
de Gaetano, G1

Other Studies

1 other study available for imipramine and Leukemia, Myeloid

ArticleYear
Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
    Scandinavian journal of haematology, 1985, Volume: 34, Issue:2

    Topics: Adult; Aged; Biological Transport, Active; Blood Platelets; Female; Humans; Imipramine; Kinetics; Le

1985